BioRegenx, Inc.
BRGX
$0.01
$0.0041.11%
OTC PK
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -80.60K | -178.30K | -266.90K | -18.40M | -394.90K |
| Total Depreciation and Amortization | -12.60K | 37.40K | 12.40K | 574.50K | 574.50K |
| Total Amortization of Deferred Charges | 27.00K | -1.20K | 1.50K | 14.30K | 8.60K |
| Total Other Non-Cash Items | 84.90K | 94.40K | 91.30K | 17.66M | -260.50K |
| Change in Net Operating Assets | -90.30K | 50.90K | 199.30K | 139.60K | 41.10K |
| Cash from Operations | -71.60K | 3.20K | 37.70K | -11.40K | -31.20K |
| Capital Expenditure | -6.00K | -- | -- | 0.00 | 0.00 |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | 0.00 | 0.00 |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 0.00 | -50.00K | -- | 2.70K | 0.00 |
| Cash from Investing | -6.00K | -50.00K | -- | 2.70K | 0.00 |
| Total Debt Issued | 117.50K | 30.00K | -- | 1.50K | 56.80K |
| Total Debt Repaid | -46.70K | -13.20K | -10.40K | -8.50K | -10.30K |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 70.80K | 16.80K | -10.40K | -6.90K | 46.40K |
| Foreign Exchange rate Adjustments | 7.20K | -7.20K | -2.10K | 4.00K | -2.60K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 500.00 | -37.20K | 25.20K | -11.70K | 12.70K |